EP2195022A4 - Zusammensetzungen mit einem antigen, einer amphipathischen verbindung und einem hydrophoben träger und ihre verwendungen - Google Patents
Zusammensetzungen mit einem antigen, einer amphipathischen verbindung und einem hydrophoben träger und ihre verwendungenInfo
- Publication number
- EP2195022A4 EP2195022A4 EP08800418A EP08800418A EP2195022A4 EP 2195022 A4 EP2195022 A4 EP 2195022A4 EP 08800418 A EP08800418 A EP 08800418A EP 08800418 A EP08800418 A EP 08800418A EP 2195022 A4 EP2195022 A4 EP 2195022A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antigen
- compositions
- hydrophobic carrier
- amphipathic compound
- amphipathic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000012051 hydrophobic carrier Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97719707P | 2007-10-03 | 2007-10-03 | |
PCT/CA2008/001747 WO2009043165A1 (en) | 2007-10-03 | 2008-10-02 | Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2195022A1 EP2195022A1 (de) | 2010-06-16 |
EP2195022A4 true EP2195022A4 (de) | 2012-08-01 |
Family
ID=40525804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08800418A Withdrawn EP2195022A4 (de) | 2007-10-03 | 2008-10-02 | Zusammensetzungen mit einem antigen, einer amphipathischen verbindung und einem hydrophoben träger und ihre verwendungen |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2195022A4 (de) |
JP (1) | JP5591705B2 (de) |
CN (1) | CN101815529B (de) |
AU (1) | AU2008307042B2 (de) |
BR (1) | BRPI0817484B1 (de) |
CA (1) | CA2700828C (de) |
WO (1) | WO2009043165A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009039628A1 (en) | 2007-09-27 | 2009-04-02 | Immunovaccine Technologies Inc. | Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
JP5715051B2 (ja) | 2008-06-05 | 2015-05-07 | イムノバクシーン・テクノロジーズ・インコーポレイテッドImmunovaccine Technologies Inc. | リポソーム、抗原、ポリヌクレオチド及び疎水性物質の連続相を含む担体を含む組成物 |
JP6240077B2 (ja) | 2011-10-06 | 2017-11-29 | イムノバクシーン・テクノロジーズ・インコーポレイテッドImmunovaccine Technologies Inc. | Tlr2を活性化するか、またはその活性を増加させるアジュバントを含むリポソーム組成物およびその使用 |
US10022441B2 (en) | 2013-03-27 | 2018-07-17 | Immunovaccine Technologies, Inc. | Method for improving the efficacy of a survivin vaccine in the treatment of cancer |
CN107531736B (zh) | 2015-01-06 | 2022-04-15 | 免疫疫苗科技公司 | 脂质a模拟物、其制备方法和用途 |
CN105044328A (zh) * | 2015-05-28 | 2015-11-11 | 首都医科大学附属北京佑安医院 | Elispot预包被培养板及其制备方法 |
AU2016355926A1 (en) * | 2015-11-18 | 2018-05-31 | Immunovaccine Technologies Inc. | Adjuvanting systems and water-free vaccine compositions comprising a polyi:C polynucleotide adjuvant and a lipid-based adjuvant |
CN109328070A (zh) * | 2016-05-04 | 2019-02-12 | 免疫疫苗技术有限公司 | 包含两亲化合物、新抗原和疏水载体的疫苗组合物及其使用方法 |
EP3518963A4 (de) | 2016-09-27 | 2020-06-10 | ImmunoVaccine Technologies Inc. | Verfahren zur verwendung von b-zell-epitop-zusammensetzungen mit niedrig dosiertem volumen zur induzierung einer antikörperimmunreaktion bei personen |
AU2019239785A1 (en) * | 2018-03-20 | 2020-10-08 | Immunovaccine Technologies Inc. | Methods and compositions for targeted delivery of active agents and immunomodulatory agents to lymph nodes |
KR20230147135A (ko) * | 2021-02-16 | 2023-10-20 | 백시테크 노쓰 아메리카, 인크. | 친양쪽성 펩티드에 기초한 자기-어셈블리 나노입자 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0640347A1 (de) * | 1992-03-03 | 1995-03-01 | Daiichi Pharmaceutical Co., Ltd. | Orale impfstoffe |
WO1996014871A1 (en) * | 1994-11-15 | 1996-05-23 | Cortecs Limited | Immunogenic compositions |
US5736141A (en) * | 1992-06-05 | 1998-04-07 | Dalhousie University | Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant |
WO1998053799A2 (en) * | 1997-05-28 | 1998-12-03 | Jenner Biotherapies, Inc. | Immunogenic compositions |
WO2002038175A1 (en) * | 2000-11-07 | 2002-05-16 | Immunovaccine Technologies Inc. | Vaccines with enhanced immune response and methods for their preparation |
WO2007041832A1 (en) * | 2005-10-07 | 2007-04-19 | Immunovaccine Technologies Inc. | Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6956021B1 (en) * | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
-
2008
- 2008-10-02 BR BRPI0817484-9A patent/BRPI0817484B1/pt not_active IP Right Cessation
- 2008-10-02 EP EP08800418A patent/EP2195022A4/de not_active Withdrawn
- 2008-10-02 WO PCT/CA2008/001747 patent/WO2009043165A1/en active Application Filing
- 2008-10-02 JP JP2010527303A patent/JP5591705B2/ja active Active
- 2008-10-02 CN CN200880110239.7A patent/CN101815529B/zh active Active
- 2008-10-02 AU AU2008307042A patent/AU2008307042B2/en not_active Ceased
- 2008-10-02 CA CA2700828A patent/CA2700828C/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0640347A1 (de) * | 1992-03-03 | 1995-03-01 | Daiichi Pharmaceutical Co., Ltd. | Orale impfstoffe |
US5736141A (en) * | 1992-06-05 | 1998-04-07 | Dalhousie University | Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant |
WO1996014871A1 (en) * | 1994-11-15 | 1996-05-23 | Cortecs Limited | Immunogenic compositions |
WO1998053799A2 (en) * | 1997-05-28 | 1998-12-03 | Jenner Biotherapies, Inc. | Immunogenic compositions |
WO2002038175A1 (en) * | 2000-11-07 | 2002-05-16 | Immunovaccine Technologies Inc. | Vaccines with enhanced immune response and methods for their preparation |
WO2007041832A1 (en) * | 2005-10-07 | 2007-04-19 | Immunovaccine Technologies Inc. | Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
Non-Patent Citations (2)
Title |
---|
HENRY D. STONE: "Newcastle Disease Oil Emulsion Vavvines Prepared with Animal, Vegetable, ans Synthetic Oils", AVIAN DISEASES, vol. 41, 1997, pages 591 - 597, XP008152979 * |
See also references of WO2009043165A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2195022A1 (de) | 2010-06-16 |
CA2700828A1 (en) | 2009-04-09 |
CA2700828C (en) | 2017-01-24 |
JP5591705B2 (ja) | 2014-09-17 |
CN101815529B (zh) | 2016-03-09 |
AU2008307042B2 (en) | 2014-01-30 |
BRPI0817484B1 (pt) | 2021-08-17 |
JP2010540570A (ja) | 2010-12-24 |
CN101815529A (zh) | 2010-08-25 |
WO2009043165A1 (en) | 2009-04-09 |
AU2008307042A1 (en) | 2009-04-09 |
BRPI0817484A2 (pt) | 2015-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2195022A4 (de) | Zusammensetzungen mit einem antigen, einer amphipathischen verbindung und einem hydrophoben träger und ihre verwendungen | |
HK1214947A1 (zh) | 抗體製劑 | |
PL2035457T3 (pl) | Nośnik szczepionki | |
IL193408A0 (en) | Antibody formulation | |
EP2077859A4 (de) | Antikörper-formulierung | |
GB0714963D0 (en) | Compositions comprising antigens | |
EP2091837A4 (de) | Wiederverschliessbare verpackung | |
EP2081453A4 (de) | Push-up-bh | |
TWI368329B (en) | Semiconductor decice | |
EP2040718A4 (de) | Galliumnitrid-formulierungen | |
GB2445682B (en) | Powder handling device | |
GB0619519D0 (en) | Packet scheduling | |
EP2056709A4 (de) | Zweifachsensibilisator mit lumineszenzverbindungen, konjugaten und verwendung | |
EP2018782A4 (de) | Scheduler | |
EP2015785A4 (de) | Agrm2-antigen | |
EP2080923A4 (de) | Einwegkupplung | |
GB0601984D0 (en) | Carrier bag | |
SG137712A1 (en) | An improved spreader assembly | |
EP2018095A4 (de) | Geräteträger | |
TWI348198B (en) | Wafer carrier | |
GB0609165D0 (en) | Envelope | |
PT1849714E (pt) | Embalagem secundária | |
AU2006904720A0 (en) | Load Carrier | |
GB0623913D0 (en) | Improved carrier | |
GB0605952D0 (en) | Carrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100329 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120628 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 47/24 20060101ALI20120622BHEP Ipc: A61K 47/48 20060101ALI20120622BHEP Ipc: A61P 31/00 20060101ALI20120622BHEP Ipc: A61K 47/06 20060101ALI20120622BHEP Ipc: A61K 39/39 20060101AFI20120622BHEP |
|
17Q | First examination report despatched |
Effective date: 20130626 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20170516 |